ReShape Lifesciences Inc (RSLS)

[rouge Vaughn]

The shares of ReShape Lifesciences Inc. (NASDAQ:RSLS) during the trading session on Thursday, trading at $0.04. At the moment, the company has a debt-to-equity ratio of 0.00, a current ratio of 0.60 , and a quick ratio of 0.40 . The stock has a 52-week low of $0.04 while its 52-weeks high is $39.00. The total market cap for the stock is $1.99M its price-to-earnings-growth ratio reads 0.71 while it has a beta of 1.77.

RSLS has flown up as the subject of gossips for a number of analysts. Analysts at the shares of ReShape Lifesciences Inc to when they released a research note on September 20th, 2018. analysts the shares of ReShape Lifesciences Inc. to in a research note they presented on September 20th, 2018 but they now have set a price target of $175, which is decrease from the previous $190. Analysts at the shares of ReShape Lifesciences Inc. to when they released a research note on September 20th, 2018, but they now have set a price target 72 dollars